Pathway maps

Mucin expression in CF via IL-6, IL-17 signaling pathways
Mucin expression in CF via IL-6, IL-17 signaling pathways

Object List (links open in MetaCore):

Chloride ion cytosol, Flagellin (P. aeruginosa), TLR2, IL-17, IL-17 receptor, Mucin 5AC, Mucin 5B, STAT3, c-Jun, IL-17F, Erk1/2, JAK2, IKK-beta, JAK2, CIKS, c-Jun, AP-1, STAT3, asialo- ganglioside GA1, IKK (cat), TLR5, TAK1, Erk1/2, TRAF6, I-kB, c-Jun/c-Fos, PilA (P. aeruginosa), None, NF-kB, ROR-gamma, Chloride ion extracellular region, IL-17RC, SP1, IL-6 receptor, IKK-gamma, IL-6, c-Jun/c-Fos, c-Fos, CFTR

Description

Mucin expression in CF via IL-6, IL-17 signaling pathways

Cystic Fibrosis (CF) is a potentially lethal genetic disease that typically results in the development of bronchial inflammation, bronchiectasis, the progressive loss of lung function and ultimately death [1].

CF was initially called "mucoviscidosis" because of copious amounts of "mucoproteins" in the respiratory and gastrointestinal tracts of CF patients [2].

CF is a recessive genetic disease caused by mutations in the CFTR gene, which encodes the Cystic Fibrosis Transmembrane Conductance Regulator ( CFTR ), a chloride channel. Expression of mutant CFTR in CF respiratory cells results in defective chloride secretion and elevated sodium absorption, resulting in altered salt concentrations in airway secretions. Alterations in mucus volume may impact mucus hydration, and thus the rheology of CF airway mucus to increase susceptibility to infection in CF airways. Lack of functional CFTR in lung cells could engender a hyperinflammatory state that alters homeostasis in CF airways. Inflammatory mediators in the airways of CF can enhance expression of mucin genes, contributing to recurring cycles of infection followed by increased expression of mucins that culminates in airway obstruction with mucus [2].

Pseudomonas aeruginosa is the predominant pathogen of CF chronic lung infection [3]. Reduced secretion of chloride and fluid hydration, as well as excessive secretion of mucins, produce a biological matrix that facilitates growth of P. aeruginosa in biofilm [1].

Mucus/gel-forming mucins are secreted by airway cells, and these mucins are subject to regulation by CF inflammatory stimuli. Mucin 5AC and Mucin 5B have been identified as major gel-forming macromolecules [2].

In normal human airways, Mucin 5AC is mainly expressed in surface goblet epithelial cells, whereas Mucin 5B is predominantly expressed in mucous cells of submucosal glands [4], [5], [2], [6]. However, Mucin 5B gene products in diseased airways (e.g. in CF or asthma) are also found in the surface epithelium, rather than just being limited to the submucosal glands [7], [8], [5], [9]. The expression of Mucin 5B might be a result of goblet cell hyperplasia and mucus hypersecretion associated with various airway diseases [5], [10].

A wide variety of stimuli present in the airways of patients with CF (eg, Pseudomonas aeruginosa components and proinflammatory cytokines) are known to cause mucin overproduction.

P. aeruginosa components flagellin ( Flagellin P. aeruginosa ) and pilin ( PilA P. aeruginosa ) are recognized by the surface receptors: asialo-GM1 ganglioside ( asialo-ganglioside GA1) and Toll-like receptors (TLRs) [11], [12], [3].

Flagellin (P. aeruginosa) is recognized by TLR5 [3]. Flagellin (P. aeruginosa) [13] and PilA (P. aeruginosa) [14] bind bacteria to the host cell glycolipid receptor, asialo-ganglioside GA1. TLR2 forms a receptor complex with asialo-ganglioside GA1 and activates NF-kB signaling [15], [16], [3]. P. aeruginosa products have been reported to upregulate mucin genes expression [17], [18].

Epithelial response to CF bacterial ligands is mediated by TLRs and also results in the expression of proinflammatory cytokines, including Interleukin 6 ( IL-6 ) [3]. IL-6 can induce T-cells to produce Interleukin IL-17 via Janus Kinase 2 ( Jak2 )/ Signal Transducer and Activator of Transcription 3 ( STAT3 )/ Retinoic Acid Receptor-Related Orphan Receptor Gamma-T ( ROR-gamma ) pathway [1], [19]. ROR-gamma is specific transcriptional regulator, critical for the expression of two members of Interleukin-17 family, IL-17A ( IL-17 ) and IL-17F [20], [21].

IL-17 is a pro-inflammatory cytokine that is secreted primarily by T cells, while IL-6 is secreted by a wide variety of cells including inflammatory (e.g. T-cells, macrophages), stromal (e.g. fibroblast, smooth muscle), and epithelial cells (e.g. airway, renal tubular) [22], [1].

In the diseased airway epithelium, both IL-6 and IL-17 are involved in the expression of mucin genes, Mucin 5AC and Mucin 5B. IL-6 is proposed to induce the expression of Mucin 5B, probably via Jak2/ STAT3 signaling and ERK1/2 pathway [10], [23].

Little is known about the mechanisms of IL-17 receptor signaling. IL-17 signals through the Interleukin 17 Receptor A ( IL-17 receptor ) that can associate with Interleukin 17 Receptor C ( IL-17RC ) to form a multimeric receptor complex [24]. IL-17RC binds both IL-17F and IL-17 [25]. Upon stimulation with IL-17, TRAF3 Interacting Protein 2 ( CIKS ) is supposed to be recruited to IL-17 receptor, followed by activation of TRAF6 and Mitogen-Activated Protein Kinase Kinase Kinase 7 ( TAK1 ), which mediate downstream activation of transcription factor NF-kB [26], [27].

Because IL-17 signaling results in the NF-kB -dependent induction of IL-6, Mucin 5B expression is at least partly upregulated by IL-17 through IL-6 by JAK2 -dependent autocrine/paracrine loop [10].

Expression of Mucin 5AC and Mucin 5B in response to IL-17 has also been proposed to depend on JAK2/ STAT3 and ERK1/2 signaling [28], [10], [2]. Several transcription factors, including NF-kB, c-Jun/c-Fos and SP1, can be involved in Mucin 5AC and Mucin 5B transcription [2], [18].

References:

  1. Dubin PJ, McAllister F, Kolls JK
    Is cystic fibrosis a TH17 disease? Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2007 Jun;56(6):221-7
  2. Rose MC, Voynow JA
    Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiological reviews 2006 Jan;86(1):245-78
  3. G??mez MI, Prince A
    Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Current opinion in pharmacology 2007 Jun;7(3):244-51
  4. Reid CJ, Gould S, Harris A
    Developmental expression of mucin genes in the human respiratory tract. American journal of respiratory cell and molecular biology 1997 Nov;17(5):592-8
  5. Groneberg DA, Eynott PR, Oates T, Lim S, Wu R, Carlstedt I, Nicholson AG, Chung KF
    Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respiratory medicine 2002 Feb;96(2):81-6
  6. Hays SR, Fahy JV
    Characterizing mucous cell remodeling in cystic fibrosis: relationship to neutrophils. American journal of respiratory and critical care medicine 2006 Nov 1;174(9):1018-24
  7. Wickstrm C, Davies JR, Eriksen GV, Veerman EC, Carlstedt I
    MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. The Biochemical journal 1998 Sep 15;334 ( Pt 3):685-93
  8. Chen Y, Zhao YH, Di YP, Wu R
    Characterization of human mucin 5B gene expression in airway epithelium and the genomic clone of the amino-terminal and 5'-flanking region. American journal of respiratory cell and molecular biology 2001 Nov;25(5):542-53
  9. Yuan-Chen Wu D, Wu R, Reddy SP, Lee YC, Chang MM
    Distinctive epidermal growth factor receptor/extracellular regulated kinase-independent and -dependent signaling pathways in the induction of airway mucin 5B and mucin 5AC expression by phorbol 12-myristate 13-acetate. The American journal of pathology 2007 Jan;170(1):20-32
  10. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, Wu R
    Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. The Journal of biological chemistry 2003 May 9;278(19):17036-43
  11. Gibson RL, Burns JL, Ramsey BW
    Pathophysiology and management of pulmonary infections in cystic fibrosis. American journal of respiratory and critical care medicine 2003 Oct 15;168(8):918-51
  12. Adamo R, Sokol S, Soong G, Gomez MI, Prince A
    Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. American journal of respiratory cell and molecular biology 2004 May;30(5):627-34
  13. McNamara N, Khong A, McKemy D, Caterina M, Boyer J, Julius D, Basbaum C
    ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. Proceedings of the National Academy of Sciences of the United States of America 2001 Jul 31;98(16):9086-91
  14. Comolli JC, Waite LL, Mostov KE, Engel JN
    Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa. Infection and immunity 1999 Jul;67(7):3207-14
  15. Li J, Johnson XD, Iazvovskaia S, Tan A, Lin A, Hershenson MB
    Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells. American journal of physiology. Lung cellular and molecular physiology 2003 Feb;284(2):L307-15
  16. Soong G, Reddy B, Sokol S, Adamo R, Prince A
    TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. The Journal of clinical investigation 2004 May;113(10):1482-9
  17. Li D, Gallup M, Fan N, Szymkowski DE, Basbaum CB
    Cloning of the amino-terminal and 5'-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. The Journal of biological chemistry 1998 Mar 20;273(12):6812-20
  18. Voynow JA, Gendler SJ, Rose MC
    Regulation of mucin genes in chronic inflammatory airway diseases. American journal of respiratory cell and molecular biology 2006 Jun;34(6):661-5
  19. Laurence A, O'Shea JJ
    T(H)-17 differentiation: of mice and men. Nature immunology 2007 Sep;8(9):903-5
  20. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR
    The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006 Sep 22;126(6):1121-33
  21. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C
    STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. The Journal of biological chemistry 2007 Feb 3;
  22. Kamimura D, Ishihara K, Hirano T
    IL-6 signal transduction and its physiological roles: the signal orchestration model. Reviews of physiology, biochemistry and pharmacology. 2003;149:1-38
  23. Inoue D, Numasaki M, Watanabe M, Kubo H, Sasaki T, Yasuda H, Yamaya M, Sasaki H
    IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. Biochemical and biophysical research communications 2006 Sep 8;347(4):852-8
  24. Toy D, Kugler D, Wolfson M, Vanden Bos T, Gurgel J, Derry J, Tocker J, Peschon J
    Cutting edge: interleukin 17 signals through a heteromeric receptor complex. Journal of immunology (Baltimore, Md. : 1950) 2006 Jul 1;177(1):36-9
  25. Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K, Harder B, Okada S, Ostrander CD, Kreindler JL, Aujla SJ, Reardon B, Moore M, Shea P, Schreckhise R, Bukowski TR, Presnell S, Guerra-Lewis P, Parrish-Novak J, Ellsworth JL, Jaspers S, Lewis KE, Appleby M, Kolls JK, Rixon M, West JW, Gao Z, Levin SD
    Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F. Journal of immunology (Baltimore, Md. : 1950) 2007 Oct 15;179(8):5462-73
  26. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X
    The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nature immunology 2007 Mar;8(3):247-56
  27. Maitra A, Shen F, Hanel W, Mossman K, Tocker J, Swart D, Gaffen SL
    Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proceedings of the National Academy of Sciences of the United States of America 2007 May 1;104(18):7506-11
  28. Subramaniam SV, Cooper RS, Adunyah SE
    Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17. Biochemical and biophysical research communications 1999 Aug 19;262(1):14-9